Mikart, a pharmaceutical contract development and manufacturing organization (CDMO), has acquired a state-of-the-art Korsch XM12 to meet their pharmaceutical client demands for complex formulation development and production of oral solid dose products.   Mikart has a 45-year history as a CDMO for solid oral and liquid oral formulation development and manufacturing.    “Adding this equipment will help our earlier clinical phase clients with the development of their fixed dose combination (FDC...